Registry of intra-articular hyaluronic acid in the treatment of knee osteoarthritis in Argentina

  • Mario Berenstein Equipo Traumatológico Olleros, Olleros 2411, Piso 10°2, Ciudad Autónoma de Buenos Aires, Argentina Tel: +5411 4778-6329; Cel 154-4064751 Mail personal: marioberenstein@gmail.com http://orcid.org/0000-0002-7521-0956
  • Leonardo Tacus Investigaciones Artroscópicas (IAR) Av Las Heras 1947, Piso 8 Ciudad Autónoma de Buenos Aires, Argentina http://orcid.org/0000-0001-8149-4097
  • Pablo Kobrinsky Investigaciones Artroscópicas (IAR) Av Las Heras 1947, Piso 8 Ciudad Autónoma de Buenos Aires, Argentina
  • Daniel Vaineras Equipo Traumatológico Olleros, Olleros 2411, Piso 10°2, Ciudad Autónoma de Buenos Aires, Argentina http://orcid.org/0000-0003-2741-3756
DOI: https://doi.org/10.15417/issn.1852-7434.2019.84.2.846
Keywords: Intra-articular, hyaluronic acid, knee, arthrosis, osteoarthritis

Abstract

Background: Intra-articular treatment of knee osteoarthrosis (OA) with hyaluronic acid (IA-HA) is frequently used in Argentina, with different dosing forms and injection regimens. Our main objective was to provide real world data on the use and effectiveness of IA-HAMethods: In this observational retrospective cohort study we studied 1227 patients with knee osteoarthrosis treated with IA-HA 20mg/2ml weekly (76%-20mg group) and 40mg/2ml (24%-40mg group) according to usual practice intervals. Follow up was at 6 months and efficacy assessed by 5 point Likert scale and 50% or more response rate.Results: Median number of applications was 5 (20mg) and 3 (40mg). Both groups had a significant improvement in the Likert scale from baseline to 6 month. Median score improved from 4 (mean 3.77 ±0.69) at baseline to median of 2 (mean 1.99 ±0.76) at 6 months (20mg group, p <0.001) and from median of 4 (mean 3.65 ±0.65) to median 2 (mean 1.86 ±0.72) in the 40mg group, p <0.001. Proportion of patients with 50% or more 6 month response were 61% and 66% respectively. In the multivariate analysis, 50% response rate was associated with higher baseline score, younger age and shorter duration of disease. Only 1 patient in the 20mg group (0.1%) experienced a serious treatment related adverse event (septic arthritis) following injection.Conclusion: Our study in common clinical practice supports the effectiveness of IA-HA in step management of knee OA with clinical benefit observed at 6 month follow up. 

Downloads

Download data is not yet available.

References

-Hussain SM, Neilly DW, Baliga S, Patil S, Meek R. Knee osteoarthritis: a review of management options. Scott Med J. 2016 Feb;61(1):7-16.

-Lespasio MJ, Piuzzi NS, Husni ME, Muschler GF, Guarino A, Mont MA. Knee Osteoarthritis: A Primer. Perm J. 2017;21.

- Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Clin Geriatr Med. 2010 Aug;26(3):355-69.

-Altman RD, Manjoo A, Fierlinger A, Niazi F, Nicholls M. The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review. BMC Musculoskelet Disord. 2015 Oct 26;16:321.

-Nicholls MA, Fierlinger A, Niazi F, Bhandari M. The Disease-Modifying Effects of Hyaluronan in the Osteoarthritic Disease State. Clin Med Insights Arthritis Musculoskelet Disord. 2017 Aug 11;10:1179544117723611.

-Hiramitsu T, Yasuda T, Ito H, Shimizu M, Julovi SM, Kakinuma T, Akiyoshi M, Yoshida M, Nakamura T. Intercellular adhesion molecule-1 mediates the inhibitory effects of hyaluronan on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts via down-regulation of NF-kappaB and p38. Rheumatology (Oxford). 2006 Jul;45(7):824-32.

-Lindqvist U, Tolmachev V, Kairemo K, Aström G, Jonsson E, Lundqvist H. Elimination of stabilised hyaluronan from the knee joint in healthy men. Clin Pharmacokinet. 2002;41(8):603-13.

-Strand, V., McIntyre, L. F., Beach, W. R., Miller, L. E. & Block, J. E. Safety and efficacy of US-approved viscosupplements for knee osteoarthritis: a systematic review and meta-analysis of randomized, saline-controlled trials. J Pain Res 8, 217–228 (2015).

-Rutjes, A. W., Juni, P., da, C. B. R., Trelle, S., Nuesch, E. & Reichenbach, S. Viscosupplementation for osteoarthritis of the knee: a systematic review and meta-analysis. Ann. Intern. Med.157, 180–191 (2012).

-Miller, L. E. & Block, J. E. US-Approved IA-HA Injections are Safe and Effective in Patients with Knee Osteoarthritis: Systematic Review and Meta-Analysis of Randomized, Saline-Controlled Trials. Clin Med Insights Arthritis Musculoskelet Disord 6, 57–63 (2013).

-Lo, G. H., LaValley, M., McAlindon, T. & Felson, D. T. IA-HA in treatment of knee osteoarthritis: a meta-analysis. JAMA 290, 3115–3121 (2003).

-Wang, C. T., Lin, J., Chang, C. J., Lin, Y. T. & Hou, S. M. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am 86-A, 538–545 (2004).

-Arrich, J., Piribauer, F., Mad, P., Schmid, D., Klaushofer, K. & Mullner, M. IA-HA for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ 172, 1039–1043 (2005).

-Bellamy, N. et al. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev doi: 10.1002/14651858.CD005321.pub2 (2006).

-Altman RD, Farrokhyar F, Fierlinger A, Niazi F, Rosen J. Analysis for Prognostic Factors from a Database for the IA-HA (Euflexxa) Treatment for Osteoarthritis of the Knee. Cartilage. 2016 Jul;7(3):229-37.

-Bowman EN, Hallock JD, Throckmorton TW, Azar FM. Hyaluronic acid injections for osteoarthritis of the knee: predictors of successful treatment. Int Orthop. 2018 Jan 3. doi: 10.1007/s00264-017-3731-8.

-Altman RD, Bedi A, Karlsson J, Sancheti P, Schemitsch E. Product Differences in IA-HAs for Osteoarthritis of the Knee. Am J Sports Med. 2016 Aug;44(8):2158-65.

-Colen, S., van den Bekerom, M. P., Mulier, M. & Haverkamp, D.Hyaluronic acid in the treatment of knee osteoarthritis: a systematic review and meta-analysis with emphasis on the efficacy of different products. BioDrugs 26, 257–268 (2012).

-Concoff A, Sancheti P, Niazi F, Shaw P, Rosen J. The efficacy of multiple versus single hyaluronic acid injections: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2017 Dec 21;18(1):542.

-Sun SF, Hsu CW, Lin HS, Liou IH, Chen YH, Hung CL. Comparison of Single Intra-Articular Injection of Novel Hyaluronan (HYA-JOINT Plus) with Synvisc-One for Knee Osteoarthritis: A Randomized, Controlled, Double-Blind Trial of Efficacy and Safety. J Bone Joint Surg Am. 2017 Mar 15;99(6):462-471.

- Conrozier T, Eymard F, Afif N, Balblanc JC, Legré-Boyer V, Chevalier X; Happyvisc Study Group. Safety and efficacy of intra-articular injections of a combination of hyaluronic acid and mannitol (HAnOX-M) in patients with symptomatic knee osteoarthritis: Results of a double-blind, controlled, multicenter, randomized trial. Knee. 2016 Oct;23(5):842-8.

- Bruyère O, Cooper C, Pelletier JP, Maheu E, Rannou F, Branco J, Luisa Brandi M, Kanis JA, Altman RD, Hochberg MC, Martel-Pelletier J, Reginster JY. A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis-From evidence-based medicine to the real-life setting. Semin Arthritis Rheum. 2016 Feb;45(4 Suppl):S3-11.

Published
2019-05-02
How to Cite
Berenstein, M., Tacus, L., Kobrinsky, P., & Vaineras, D. (2019). Registry of intra-articular hyaluronic acid in the treatment of knee osteoarthritis in Argentina. Revista De La Asociación Argentina De Ortopedia Y Traumatología, 84(2), 122-128. https://doi.org/10.15417/issn.1852-7434.2019.84.2.846
Issue
Vol 84 No 2 (2019)
Section
Clinical Research

Copyright (c) 2019 Revista de la Asociación Argentina de Ortopedia y Traumatología

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Manuscript acceptance by the Journal implies the simultaneous non-submission to any other journal or publishing house. The RAAOT is under the Licencia Creative Commnos Atribución-NoComercial-Compartir Obras Derivadas Igual 4.0 Internacional (CC-BY-NC.SA 4.0) (http://creativecommons.org/licences/by-nc-sa/4.0/deed.es). Articles can be shared, copied, distributed, modified, altered, transformed into a derivative work, executed and publicly communicated, provided a) the authors and the original publication (Journal, Publisher and URL) are mentioned, b) they are not used for commercial purposes, c) the same terms of the license are maintained.

In the event that the manuscript is approved for its next publication, the authors retain the copyright and will assign to the journal the rights of publication, edition, reproduction, distribution, exhibition and communication at a national and international level in the different databases. data, repositories and portals.

It is hereby stated that the mentioned manuscript has not been published and that it is not being printed in any other national or foreign journal.

The authors hereby accept the necessary modifications, suggested by the reviewers, in order to adapt the manuscript to the style and publication rules of this Journal.